Copyright
©The Author(s) 2017.
World J Gastroenterol. Mar 28, 2017; 23(12): 2258-2265
Published online Mar 28, 2017. doi: 10.3748/wjg.v23.i12.2258
Published online Mar 28, 2017. doi: 10.3748/wjg.v23.i12.2258
Table 1 Clinical, pathological, immunohistochemical and genetic features of clear-cell sarcoma of the gastrointestinal tract in previously reported cases
| Ref. | Age (yr)/sex | Location | Maximum diameter of tumor(cm) | S-100 | HMB-45 | Melan-A | Genetic findings | Outcome |
| Alpers et al[5] | 26/F | Jejunum | 1.5 | ND | ND | ND | ND | Liver mets |
| Ekfors et al[3] | 38/M | Duodenum | 3.0 | Positive | Positive | ND | ND | Not given |
| Donner et al[6] | 37/M | Ileum | 6.5 | Positive | Negative | ND | t(12;22)(q13;q12-13) | Liver mets at 24 and 36 mo |
| Fukuda et al[7] | 74/M | Colon | 3.0 | Positive | Positive | ND | EWSR1-ATF1 by RT-PCR | Liver mets at 9 mo |
| Hu et al[8] | 10/M | Rectum | 5.0 | Positive | Positive | ND | ND | NA |
| Pauwels et al[9] | 30/M | Stomach | 4.0 | Positive | Negative | ND | t(12;22)(q13;q12) | LN and peritoneal mets at diagnosis |
| Zambrano et al[10] | 15/F | Jejunum | 5.0 | Positive | Negative | Negative | t(12;22)(q13;q12) | DOD 16 mo |
| 21/F | Jejunum | 4.0 | Positive | Negative | Negative | ND | DOD 12 mo | |
| 35/F | Ileum | 3.5 | Positive | Negative | Negative | ND | Liver mets at 12 mo | |
| 37/F | Ileum | 4.5 | Positive | Negative | Negative | ND | NA | |
| 32/M | Ileum | 5.0 | Positive | Negative | Negative | ND | NA | |
| 13/M | Stomach | 6.7 | Positive | Negative | Negative | ND | Local recurrence at 12 mo;2nd Local recurrence at 36 mo | |
| Achten et al[11] | 57/M | Jejunum | 6.5 | Positive | Negative | Negative | EWSR1 rearrangement by FISH | NA |
| Venkataraman et al[12] | 21/F | Ileum | 7.0 | Positive | Negative | Negative | EWSR1 rearrangement by FISH | NA |
| Covinsky et al[13] | 47/F | Pancreas | NA | Positive | Positive | Positive | EWSR1-ATF1 | NED 24 mo |
| by RT-PCR and | ||||||||
| FISH | ||||||||
| 85/F | Mesentery | NA | Positive | Positive | Positive | EWSR1-ATF1 | DOD 1 mo | |
| by RT-PCR and | ||||||||
| FISH | ||||||||
| Taminelli et al[14] | 35/M | Ileum | 1.8 | Positive | Negative | Positive | EWSR1-ATF1/ by RT-PCR | DOD 15 mo |
| Friedrichs et al[15] | 41/M | Jejunum | 8.7 | Positive | Negative | Negative | EWSR1 rearrangement by FISH | Liver mets at 6 mo |
| Huang et al[16] | 40/M | Stomach | 3.0 | Positive | Negative | Positive | ND | NED 9 mo |
| Antonescu et al[17] | 81/F | Colon | 7.5 | Positive | Negative | Negative | EWSR1-CREB1 by RT-PCR | Mets to liver and |
| peritoneum at | ||||||||
| 60 mo | ||||||||
| 42/F | Ileum | 5.7 | Positive | Negative | Negative | EWSR1-CREB1 by RT-PCR | NA | |
| 42/F | Ileum | 3.5 | Positive | Negative | Negative | EWSR1-CREB1 by RT-PCR | Peritoneal and | |
| liver mets at | ||||||||
| diagnosis | ||||||||
| 51/F | Jejunum | NA | Positive | Negative | Negative | EWSR1 | Peritoneal and | |
| rearrangement | liver mets; AWD | |||||||
| by FISH | ||||||||
| 18/F | Jejunum | NA | Positive | Negative | Negative | EWSR1-ATF1 by RT-PCR | Local recurrence | |
| Granville et al[18] | 16/M | Ileum | 5.0 | Positive | Negative | ND | EWSR1-ATF1 by RT-PCR; t(12;22)(q13;q12) | DOD 15 mo |
| Comin et al[19] | 31/F | Ileum | 2.8 | Positive | Negative | Negative | EWSR1 rearrangement by FISH | NA |
| Lyle et al[20] | 46/M | Jejunum | 11.0 | Positive | Positive | Positive | EWSR1 rearrangement by FISH; EWSR1-ATF1 by RT-PCR | NED 7 mo |
| 49/M | Cecum | 10.5 | Positive | Positive | Positive | EWSR1 rearrangement by FISH; EWSR1-ATF1 by RT-PCR | DOD 12 mo | |
| 60/M | Jejunum | 10.0 | Positive | Positive | Positive | EWSR1-ATF1 by RT-PCR | DOD 28 mo | |
| 62/M | Ileum | 4.0 | Positive | Positive | Positive | EWSR1 rearrangement by FISH; EWSR1-ATF1 by RT-PCR | DOD 12 mo | |
| Abdulkader et al[21] | 37/M | Jejunum | 8.2 | Positive | Negative | ND | EWSR1 rearrangement by FISH | Liver mets at 2 mo |
| Lagmay et al[22] | 10/F | Stomach | 7.8 | Positive | Negative | Negative | EWSR1 rearrangement by FISH; EWSR1-ATF1 by RT-PCR | NED 4 mo |
| Joo et al[23] | 60/M | Ileum | 2.4 | Positive | Negative | Negative | EWSR1 rearrangement by FISH | NA |
| 46/M | Jejunum | 6.0 | Positive | Negative | Negative | EWSR1 rearrangement by FISH | NA | |
| Terazawa et al[24] | Early 20s/F | Ileum | 3.0 | Positive | ND | ND | EWSR1-ATF1 by RT-PCR | NED at 24 mo |
| Shenjere et al[25] | 53/F | Ileum | 5.0 | Positive | Negative | Negative | EWSR1-ATF1 by RT-PCR | Regional LN mets at diagnosis/ NED at 7 mo |
| 26/F | Small and large bowel1 | 13.5/10.1 | Positive | Negative | Negative | EWSR1-CREB1 by RT-PCR | NA | |
| 66/M | Ileum | 2.5 | Positive | Negative | Negative | EWSR1-CREB1 by RT-PCR | Regional LN mets at diagnosis/NED | |
| Balkaransingh et al[26] | 15/M | Ileum | NA | ND | ND | ND | EWSR1 rearrangement by FISH | NA |
| Yang et al[27] | 15/M | Ileum | 4.0 | Positive | ND | ND | EWSR1 rearrangement by FISH | Liver mets at 12 mo |
| Suárez-Vilela et al[28] | 36/F | Jejunum | 1.5 | Positive | Negative | Negative | EWSR1 rearrangement by FISH | NA |
| D’Amico et al[29] | 69/F | Ileum | 4.0 | Positive | Negative | ND | EWSR1 rearrangement by FISH | Liver mets at 2 mo |
| Lasithiotakis et al[30] | 49/F | Jejunum | 3.0 | Positive | Negative | Negative | EWSR1 rearrangement by FISH | NED 20 mo |
| Huang et al[31] | 45/F | Colon | 4.0 | Positive | Negative | Negative | EWSR1 rearrangement by FISH | Liver mets at 20 mo |
| Mallick et al[32] | 45/M | Jejunum | 4.4 | Positive | Negative | Negative | ND | NA |
| Kong et al[33] | 17/M | Stomach | 6.0 | Positive | Negative | Negative | EWSR1 rearrangement by FISH | NED 10 mo |
| Liu et al[34] | 76/M | Jejunum | 2.5 | Positive | Negative | Negative | EWSR1-ATF1 by RT-PCR | NA |
| Thway et al[35] | 36/M | Ileum | 3.0 | Positive | Negative | Negative | EWSR1-CREB1 by RT-PCR | DOD 7 mo |
| Huang [36] | 36/M | Pancreas | 4.0 | Positive | Positive | Positive | EWSR1 rearrangement by FISH | Liver mets at 10 mo |
| Yegen et al[37] | 25/F | Ileum | 3.2 | Positive | Negative | Negative | EWSR1 rearrangement by FISH | Liver mets at diagnosis and at 15 mo. Ovarian mets and peritoneal dissemination at 47 mo |
| Moslim et al[38] | 57/M | Duodenum and Jejunum2 | 5.5/7.5 | Positive | Negative | Positive | EWSR1 rearrangement by FISH | NED 30 mo and then DOD 4 mo later |
| Chen et al[39] | 29/F | Jejunum | 6.0 | Positive | Negative | Negative | EWSR1 rearrangement by FISH | NED 17 mo |
| Our case | 51/M | Duodenum and Jejunum3 | 6.5/2.5/2.5 | Positive | Positive | Positive | EWSR1 rearrangement undetectable by FISH | NED up to date |
- Citation: Su H, Liu WS, Ren WH, Wang P, Shi L, Zhou HT. Multiple clear-cell sarcomas of small intestine with parotid gland metastasis: A case report. World J Gastroenterol 2017; 23(12): 2258-2265
- URL: https://www.wjgnet.com/1007-9327/full/v23/i12/2258.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i12.2258
